Christopher Gibson - Chief Executive Officer, Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Christopher Gibson - trading volume in the past year for Recursion Pharmaceuticals, Inc.

Holdings reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 954K $4.66M $4.88 Oct 10, 2025 Direct
Class B Common Stock 5.13M Oct 10, 2025 Direct Class A Common Stock 5.9M
Class B Common Stock 388K Oct 10, 2025 by LAHWRAN-4 LLC Class A Common Stock 0
Class B Common Stock 386K Oct 10, 2025 by LAHWRAN-3 LLC Class A Common Stock 0
Stock Option (Right to Buy) 283K Oct 10, 2025 Direct Class A Common Stock 0
Class B Common Stock 50K Oct 10, 2025 by Gibson Family Trust Class A Common Stock 0

Transactions reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.